Investments and investor services
Angus Energy considers sale of Brockham licences after disappointing drilling programme
A look at the day's major movers, including Rose Petroleum, Craneware, CVS, Adept4, Merlin, Mirriad and Costain
Company
LON:ONC
Oncimmune Holdings PLC is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. The company has a diversified and growing revenue from its portfolio of diagnostic products to detect early-stage cancer and a contract discovery and development service-based platform, delivering actionable insights into therapies to its pharmaceutical and biotech partners.
139 stories · page 6 of 7
Investments and investor services
A look at the day's major movers, including Rose Petroleum, Craneware, CVS, Adept4, Merlin, Mirriad and Costain
The exclusive agreement with US group Biodesix is worth up to US$28mln over five years
Investments and investor services
The mid-cap FTSE 250 added over 147 points to close at 19,462 on Friday
Commercial terms are being negotiated for the study, which is expected to commence later this year and will last approximately 24 months.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A total of 12,210 Scots were monitored for two years as part of the Early Cancer Detection Test - Lung Cancer Scotland (ECLS) initiative
Archive
A look at the day's major movers in London on Wednesday, including Yu Group, Argo Blockchain, Tavistock Investments, Finablr, Moss Bros, Speedy Hire and Indivior
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Lung cancer kills more people in Israel than any other form of the disease, said the company.
Archive
The mid-cap FTSE 250 was also a shade higher - adding around two points at 19,369
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The company’s chief executive, Dr Adam Hill, told investors: "This study is part of our ongoing programme to support the introduction of EarlyCDT-Lung in China, which is progressing to schedule."
In results for the six months to 30 November 2018, the AIM-listed firm posted a pre-tax loss of £3.85mln, wider from the £2.83mln loss recorded a year earlier, although revenues rose to £121,000 from £77,000
Archive
The more UK-company focused FTSE 250 gained over 147 points to close at 18,972
Archive
The data will have a distinctly Brexity flavour after the UK's impending exit from the bloc was blamed for lacklustre GDP growth of 0.2% in the fourth quarter of 2018 reported on Monday
Archive
Aside from all the company news, the Week Ahead also brings the latest UK inflation and GDP growth data for investors to digest, while the Brexit saga will continue to roll on
A look at some winners and losers in the UK equity market on Wednesday